{"id":49608,"date":"2025-09-24T16:59:42","date_gmt":"2025-09-24T11:29:42","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=49608"},"modified":"2025-09-24T17:00:23","modified_gmt":"2025-09-24T11:30:23","slug":"aptus-pharma-ipo-gmp-day-2","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/aptus-pharma-ipo-gmp-day-2\/","title":{"rendered":"Aptus Pharma IPO GMP: Day 2 IPO Live Updates"},"content":{"rendered":"<p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong><em>Click &amp; Sign Up to Get Latest Updates on Aptus Pharma IPO<\/em><\/strong><\/a><\/p><p>The <strong>Aptus Pharma IPO GMP <\/strong>is \u20b97 as of 24th September 2025. It is a bookbuilding IPO of \u20b913.02 crores, comprising a fresh issue of 0.19 crores. The issue will be listed on BSE and SME on its tentative listing date, 30th September 2025. The face value of Aptus Pharma shares stands at \u20b910 per share, and the IPO price band is set at \u20b965 to \u20b970 per share. Retail investors can bid for a minimum of 2 lots of 4,000 shares worth \u20b92,80,000.<\/p><div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/aptus-pharma-ipo-gmp-day-2\/#Aptus_Pharma_IPO_Grey_Market_Premium\" title=\"Aptus Pharma IPO Grey Market Premium\">Aptus Pharma IPO Grey Market Premium<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/aptus-pharma-ipo-gmp-day-2\/#Aptus_Pharma_IPO_Details\" title=\"Aptus Pharma IPO Details\">Aptus Pharma IPO Details<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/aptus-pharma-ipo-gmp-day-2\/#Explanation\" title=\"Explanation\">Explanation<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/aptus-pharma-ipo-gmp-day-2\/#Objectives_of_the_Aptus_Pharma_IPO\" title=\"Objectives of the Aptus Pharma IPO\">Objectives of the Aptus Pharma IPO<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/aptus-pharma-ipo-gmp-day-2\/#Aptus_Pharma_IPO_Registrar\" title=\"Aptus Pharma IPO Registrar\">Aptus Pharma IPO Registrar<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/aptus-pharma-ipo-gmp-day-2\/#Aptus_Pharma_IPO_Review\" title=\"Aptus Pharma IPO Review&nbsp;&nbsp;\">Aptus Pharma IPO Review&nbsp;&nbsp;<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/aptus-pharma-ipo-gmp-day-2\/#Aptus_Pharma_Limited_Technicals\" title=\"Aptus Pharma Limited Technicals\">Aptus Pharma Limited Technicals<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/aptus-pharma-ipo-gmp-day-2\/#FAQs_on_Aptus_Pharma_IPO\" title=\"FAQs on Aptus Pharma IPO\">FAQs on Aptus Pharma IPO<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/aptus-pharma-ipo-gmp-day-2\/#Recent_Articles\" title=\"Recent Articles\">Recent Articles<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Aptus_Pharma_IPO_Grey_Market_Premium\"><\/span><strong>Aptus Pharma IPO Grey Market Premium<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>As of 24th September 2025, the <strong>Aptus Pharma IPO GMP <\/strong>stands at \u20b97 per share. Thus, the estimated listing price would be \u20b977. This indicates that the estimated listing gain in this IPO could be 10.00%. However, GMP details are subject to change based on market conditions and fluctuations. Explore the table for the <strong>Aptus Pharma IPO GMP <\/strong>updates.<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>GMP Date<\/strong><\/td><td><strong>IPO Price<\/strong><\/td><td><strong>GMP<\/strong><\/td><td><strong>Estimated Listing Price&nbsp;<\/strong><\/td><td><strong>Estimated Listing Gains<\/strong><\/td><\/tr><tr><td><strong>24-09-2025<\/strong><\/td><td>\u20b972.00&nbsp;<\/td><td>\u20b97.00<\/td><td>\u20b977.00<\/td><td>10.00%<\/td><\/tr><tr><td><strong>23-09-2025<\/strong><\/td><td>\u20b972.00&nbsp;<\/td><td>\u20b97.00<\/td><td>\u20b977.00<\/td><td>10.00%<\/td><\/tr><tr><td><strong>22-09-2025<\/strong><\/td><td>\u20b972.00&nbsp;<\/td><td>\u20b97.00<\/td><td>\u20b977.00<\/td><td>10.00%<\/td><\/tr><tr><td><strong>21-09-2025<\/strong><\/td><td>\u20b972.00&nbsp;<\/td><td>\u20b97.00<\/td><td>\u20b977.00<\/td><td>10.00%<\/td><\/tr><tr><td><strong>20-09-2025<\/strong><\/td><td>\u20b972.00&nbsp;<\/td><td>\u20b97.00<\/td><td>\u20b977.00<\/td><td>10.00%<\/td><\/tr><tr><td><strong>19-09-2025<\/strong><\/td><td>\u20b972.00&nbsp;<\/td><td>\u20b97.00<\/td><td>\u20b977.00<\/td><td>10.00%<\/td><\/tr><tr><td><strong>18-09-2025<\/strong><\/td><td>\u20b972.00&nbsp;<\/td><td>\u20b90.00<\/td><td>\u20b972.00&nbsp;<\/td><td>0.00%<\/td><\/tr><\/tbody><\/table><\/figure><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Aptus_Pharma_IPO_Details\"><\/span><strong>Aptus Pharma IPO Details<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>IPO Open Date<\/strong><\/td><td>23rd September 2025<\/td><\/tr><tr><td><strong>IPO Close Date<\/strong><\/td><td>25th September 2025<\/td><\/tr><tr><td><strong>IPO Allotment Date<\/strong><\/td><td>26th September 2025<\/td><\/tr><tr><td><strong>Refund Initiation&nbsp;<\/strong><\/td><td>29th September 2025<\/td><\/tr><tr><td><strong>Issue Size<\/strong><\/td><td>18,60,000 shares(aggregating up to \u20b913.02 Cr)<\/td><\/tr><tr><td><strong>Face Value<\/strong><\/td><td>\u20b910 per share<\/td><\/tr><tr><td><strong>Lot Size<\/strong><\/td><td>2,000 shares<\/td><\/tr><tr><td><strong>Issue Price Band<\/strong><\/td><td>\u20b965.00 to \u20b970.00 per share<\/td><\/tr><tr><td><strong>Issue Type<\/strong><\/td><td>Bookbuilding IPO<\/td><\/tr><tr><td><strong>Listing At<\/strong><\/td><td>BSE &amp; SME<\/td><\/tr><tr><td><strong>Listing Date<\/strong><\/td><td>30th September 2025<\/td><\/tr><\/tbody><\/table><\/figure><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Explanation\"><\/span><strong>Explanation<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p><strong>Aptus Pharma IPO<\/strong>: Aptus Pharma Limited has declared that the issue price is set at \u20b965 to \u20b970 per share. With this IPO, the company allows retail investors to bid for two lots of 4,000 shares worth \u20b92,80,000. The face value of Aptus Pharma Limited shares is \u20b910 per share. The shares of Aptus Pharma Limited will be listed on BSE and SME on its tentative listing day, 30th September 2025. Scroll down to view GMP updates and <strong>reviews of the Aptus Pharma IPO<\/strong>.&nbsp;<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Objectives_of_the_Aptus_Pharma_IPO\"><\/span><strong>Objectives of the Aptus Pharma IPO<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>The primary aim of the <strong>Aptus Pharma IPO<\/strong> is to raise \u20b913.02 crores. On the other hand, Aptus Pharma has decided to utilise these funds in different ways. Explore some of the secondary objectives for the Aptus Pharma IPO.<\/p><ul class=\"wp-block-list\"><li>To Capital Expenditure for Office Premises with furniture and Industrial Racks<\/li>\n\n<li>To Working Capital<\/li>\n\n<li>For general corporate purposes<\/li><\/ul><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Aptus_Pharma_IPO_Registrar\"><\/span><strong>Aptus Pharma IPO Registrar<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Bigshare Services Private Limited is the registrar of the <strong>Aptus Pharma IPO,<\/strong> responsible for managing the allotment procedure and initiating refunds. For any queries regarding the Aptus Pharma allotment and refund, please contact Bigshare Services Private Limited at <a href=\"mailto:investor@bigshareonline.com\">investor@bigshareonline.com<\/a> &nbsp;or +91-22-6263 8200.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Aptus_Pharma_IPO_Review\"><\/span><strong>Aptus Pharma IPO Review&nbsp;&nbsp;<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>The <strong>Aptus Pharma IPO <\/strong>has gained neutral ratings from industry experts, brokers, and institutional investors. Aptus Pharma Limited&#8217;s revenue increased by 38% from \u20b917.88 crores in March 2024 to \u20b924.64 crores in March 2025. Moreover, the company&#8217;s PAT rose by 288% from \u20b90.80 crores to \u20b93.10 crores. Most analysts recommend applying for this IPO to diversify your investment portfolio in the stock market. However, we\u2019re waiting for further ratings to gain a better understanding and will continue to post them to deliver real-time insights. Until then, you can explore the company&#8217;s technical analysis to know whether you should apply for the <strong>Aptus Pharma IPO <\/strong>or not.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Aptus_Pharma_Limited_Technicals\"><\/span><strong>Aptus Pharma Limited Technicals<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Key Indicators<\/strong><\/td><td><strong>Value<\/strong><\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/price-to-earnings-ratio-p-e-ratio\"><strong>PE Ratio (Price-to-Earnings)<\/strong><\/a><strong>&nbsp;<\/strong><\/td><td>11.29<\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/earnings-per-share-eps-formula\"><strong>EPS (Earnings Per Share)<\/strong><\/a><\/td><td>6.20<\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/return-on-capital-employed\"><strong>ROCE<\/strong><\/a><\/td><td>45.66%<\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/return-on-equity\"><strong>ROE<\/strong><\/a><\/td><td>44.50%<\/td><\/tr><tr><td><strong>RoNW<\/strong><\/td><td>44.50%<\/td><\/tr><tr><td><strong>PAT Margin<\/strong><\/td><td>&#8211;<\/td><\/tr><tr><td><strong>EBITDA Margin<\/strong><\/td><td>19.31%<\/td><\/tr><tr><td><strong>Price to Book Value<\/strong><\/td><td>&#8211;<\/td><\/tr><tr><td><strong>Market Capitalisation<\/strong><\/td><td>\u20b948.02 Cr<\/td><\/tr><\/tbody><\/table><\/figure><p>The P\/E ratio of Aptus Pharma Limited&#8217;s shares is 11.29, and its Earnings Per Share (EPS) stands at \u20b9 6.20. Thus, the <strong>Aptus Pharma&nbsp; Limited IPO<\/strong> is expected to deliver gains on its tentative listing date, 30th September 2025.&nbsp;<\/p><p><strong><em>Note<\/em><\/strong><em>: The data, as mentioned above, is taken from authentic sources and highlights pre-issue information. The PE ratio and EPS of Aptus Pharma Limited are subject to change after the IPO. Refer to the table below for post-issue updates on these two metrics.&nbsp;<\/em><\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Indicators<\/strong><\/td><td><strong>Pre-IPO<\/strong><\/td><td><strong>Post-IPO<\/strong><\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/price-to-earnings-ratio-p-e-ratio\"><strong>PE Ratio<\/strong><\/a><\/td><td>11.29<\/td><td>4.52<\/td><\/tr><tr><td><a href=\"https:\/\/univest.in\/blogs\/earnings-per-share-eps-formula\"><strong>EPS<\/strong><\/a><strong>&nbsp;<\/strong><\/td><td>6.20<\/td><td>4.52<\/td><\/tr><\/tbody><\/table><\/figure><p><strong><em>Download <\/em><\/strong><a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\"><strong><em>Univest iOS App<\/em><\/strong><\/a><strong><em> or <\/em><\/strong><a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\"><strong><em>Univest Android App<\/em><\/strong><\/a><strong><em> to get daily stock recommendations and insightful research pieces!<\/em><\/strong><\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"FAQs_on_Aptus_Pharma_IPO\"><\/span><strong>FAQs on Aptus Pharma IPO<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><strong>What is the GMP of the Aptus Pharma IPO?<\/strong><\/p><p>Ans. As of 24th September 2025, the <strong>Aptus Pharma<\/strong> (Grey Market Premium) stands at \u20b97. This indicates that the estimated listing price could be \u20b977 per share.<\/p><p><strong>What is the issue price of the Aptus Pharma IPO?<\/strong><\/p><p>Ans. The <strong>Aptus Pharma IPO<\/strong> price is set at \u20b965.00 to \u20b970.00 per share.&nbsp; Retail investors can apply for a minimum of 2 lots consisting of 4,000 shares worth \u20b92,80,000. Moreover, HNIs are required to bid for a minimum of 3 lots (6,000 shares) worth \u20b94,20,000.<\/p><p><strong>Who is the registrar of the Aptus Pharma IPO?<\/strong><\/p><p>Ans.&nbsp; Bigshare Services Private Limited is the registrar of the <strong>Aptus Pharma IPO,<\/strong> responsible for managing the allotment procedure and initiating refunds. For any queries regarding the Aptus Pharma allotment and refund, please contact Bigshare Services Private Limited at <a href=\"mailto:investor@bigshareonline.com\">investor@bigshareonline.com<\/a> &nbsp;or +91-22-6263 8200.<\/p><p><strong><em>Disclaimer<\/em><\/strong><em>: The above information is compiled from authentic sources and is just for informational purposes. To have detailed information about the Aptus Pharma IPO, download the Aptus Pharma IPO RHP and Aptus Pharma IPO DRHP. Conduct thorough research before investing in IPOs to minimise the risk of significant losses. You can also consult your financial advisor.<\/em><\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Recent_Articles\"><\/span><strong>Recent Articles<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><a href=\"https:\/\/univest.in\/blogs\/top-10-penny-stocks-in-india\">Top 10 Penny Stocks in India&nbsp; | Penny Stocks to Buy in 2025<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/best-stocks-to-buy-today-6\">Best Stocks to Buy Today: Explore Best Stocks With Expected Trends<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/milky-mist-dairy-foods-ipo-details\">Milky Mist Dairy Foods IPO Details: Everything You Should Know about<\/a>&nbsp;<\/p><p><a href=\"https:\/\/univest.in\/blogs\/karbonsteel-engineering-ipo-gmp-review\">Karbonsteel Engineering IPO GMP &amp; Review: Should You Apply or Avoid?<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/taurian-mps-ipo-gmp-review\">Taurian MPS IPO GMP &amp; Review: Should You Apply or Avoid?<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/shringar-house-of-mangalsutra-ipo-gmp-review\">Shringar House of Mangalsutra IPO GMP &amp; Review: Apply or Avoid?<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/dev-accelerator-ipo-gmp-review\">Dev Accelerator IPO GMP &amp; Review: Apply or Avoid?<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/vigor-plast-india-ipo-listing-preview\">Vigor Plast India IPO Listing Preview: What to Expect Now?<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/krupalu-metals-ipo-gmp-live-updates-2\">Krupalu Metals IPO GMP: Day 3 IPO Live Updates<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Click &amp; Sign Up to Get Latest Updates on Aptus Pharma IPO The Aptus Pharma IPO GMP is \u20b97 as of 24th September 2025. It is a bookbuilding IPO of \u20b913.02 crores, comprising a fresh issue of 0.19 crores. The issue will be listed on BSE and SME on its tentative listing date, 30th September<\/p>\n","protected":false},"author":23,"featured_media":49610,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1281],"tags":[2353],"class_list":["post-49608","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ipo","tag-aptus-pharma-ipo-gmp"],"metadata":{"_edit_lock":["1758713424:23"],"_last_editor_used_jetpack":["block-editor"],"rank_math_internal_links_processed":["1"],"rank_math_seo_score":["82"],"rank_math_primary_category":["1281"],"rank_math_title":["Aptus Pharma IPO GMP Day 2 | Click to Check Live Updates"],"rank_math_description":["The status of Aptus Pharma IPO. Discover the IPO Price, Date, Subscription Status, Grey Market Premium GMP, Allotment, Listing Date, and Review. Read more!\r\n"],"rank_math_focus_keyword":["Aptus Pharma IPO"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"_thumbnail_id":["49610"],"_edit_last":["23"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["3386"],"_wp_page_template":["default"],"rs_page_bg_color":[""],"rank_math_canonical_url":["https:\/\/univest.in\/blogs\/aptus-pharma-ipo-gmp-day-2"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/09\/24165516\/Aptus-Pharma-IPO-GMP-Day-2.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/49608","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/23"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=49608"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/49608\/revisions"}],"predecessor-version":[{"id":49611,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/49608\/revisions\/49611"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/49610"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=49608"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=49608"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=49608"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}